Brain Stimulation (Mar 2022)

The degree of cortical plasticity correlates with cognitive performance in patients with Multiple Sclerosis

  • Carolin Balloff,
  • Iris-Katharina Penner,
  • Meng Ma,
  • Iason Georgiades,
  • Lina Scala,
  • Nina Troullinakis,
  • Jonas Graf,
  • David Kremer,
  • Orhan Aktas,
  • Hans-Peter Hartung,
  • Sven Günther Meuth,
  • Alfons Schnitzler,
  • Stefan Jun Groiss,
  • Philipp Albrecht

Journal volume & issue
Vol. 15, no. 2
pp. 403 – 413

Abstract

Read online

Background: Cortical reorganization and plasticity may compensate for structural damage in Multiple Sclerosis (MS). It is important to establish sensitive methods to measure these compensatory mechanisms, as they may be of prognostic value. Objective: To investigate the association between the degree of cortical plasticity and cognitive performance and to compare plasticity between MS patients and healthy controls (HCs). Methods: The amplitudes of the motor evoked potential (MEP) pre and post quadripulse stimulation (QPS) applied over the contralateral motor cortex served as measure of the degree of cortical plasticity in 63 patients with relapsing-remitting MS (RRMS) and 55 matched HCs. The main outcomes were the correlation coefficients between the difference of MEP amplitudes post and pre QPS and the Symbol Digit Modalities Test (SDMT) and Brief Visuospatial Memory Test-Revised (BVMT-R), and the QPSxgroup interaction in a mixed model predicting the MEP amplitude. Results: SDMT and BVMT-R correlated significantly with QPS-induced cortical plasticity in RRMS patients. Plasticity was significantly reduced in patients with cognitive impairment compared to patients with preserved cognitive function and the degree of plasticity differentiated between both patient groups. Interestingly, the overall RRMS patient cohort did not show reduced plasticity compared to HCs. Conclusions: We provide first evidence that QPS-induced plasticity may inform about the global synaptic plasticity in RRMS which correlates with cognitive performance as well as clinical disability. Larger longitudinal studies on patients with MS are needed to investigate the relevance and prognostic value of this measure for disease progression and recovery.

Keywords